ArticleJournal of the National Comprehensive Cancer Network : JNCCN2022

Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.

Quisette P Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.